Ignite Creation Date:
2024-05-05 @ 12:10 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00263731
Status:
COMPLETED
Last Update Posted:
2022-05-09
First Post:
2005-12-07
Brief Title:
Metabolomic Analysis of Lung Cancer
Sponsor:
University of Louisville
Organization:
University of Louisville
Study Overview
Official Title:
Preoperative Metabolomic Analysis of Primary Lung Cancer A Translational Clinical Trial of the Brown Cancer Center
Status:
COMPLETED
Status Verified Date:
2022-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to learn more about the metabolic properties of lung cancer cells
Detailed Description:
It has long been known that cancer cells absorb and break down substances in the body differently than healthy non-cancer cells This process of absorbing and breaking down substances is known as metabolism and is increased in cancer cells Recent research suggests that this increased metabolic activity makes it easier for cancer cells to multiply The objective of the study is to characterize the metabolism of glucose by lung tumors by serum metabolite analysis using a variant of glucose sugar which makes up 1 of glucose in nature
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| BCC-LUN-05-002 | OTHER | James Graham Brown Cancer Center Clinical Trials Office | None |